Yang, K., Challagulla, S., Chuang, P., Furnback, W., Ailawadhi, S. (2025). Real-world treatment utilization patterns, discontinuation and healthcare resource utilization of first-line (1L) bruton tyrosine kinase inhibitor (BTKi) therapy in chronic lymphocytic leukemia (CLL): Age-related disparity.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e19033